Cargando…

Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries

BACKGROUND: The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential medicines for the prevention and treatment of CVDs on national essential medicin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bazargani, Y. T., Ugurlu, M., de Boer, A., Leufkens, H. G. M., Mantel-Teeuwisse, A. K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019804/ https://www.ncbi.nlm.nih.gov/pubmed/29940880 http://dx.doi.org/10.1186/s12872-018-0858-5

Ejemplares similares

Selection of Essential Medicines for Diabetes in Low and Middle Income Countries: A Survey of 32 National Essential Medicines Lists
por: Bazargani, Yaser T., et al.
Publicado: (2014)

Essential medicines for breast cancer in low and middle income countries
por: Bazargani, Y. T., et al.
Publicado: (2015)

Essential Medicines Are More Available than Other Medicines around the Globe
por: Bazargani, Yaser T., et al.
Publicado: (2014)

Linking market authorizations of medicines with disease burden in South Africa
por: Narsai, K., et al.
Publicado: (2021)

The availability of essential medicines for cardiovascular diseases at healthcare facilities in low- and middle-income countries: The case of Bangladesh
por: Hakim, Shariful, et al.
Publicado: (2022)

Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries
por: Chow, Clara Kayei, et al.
Publicado: (2020)

Impact of External Price Referencing on Medicine Prices – A Price Comparison Among 14 European Countries
por: Leopold, Christine, et al.
Publicado: (2012)

Assessing the impact of law enforcement to reduce over-the-counter (OTC) sales of antibiotics in low- and middle-income countries; a systematic literature review
por: Jacobs, Tom G., et al.
Publicado: (2019)

Availability, prices, and affordability of selected essential cancer medicines in a middle-income country – the case of Mexico
por: Moye-Holz, Daniela, et al.
Publicado: (2020)

Factors associated with the availability and affordability of essential cardiovascular disease medicines in low- and middle-income countries: A systematic review
por: Lotfizadeh, Ali, et al.
Publicado: (2022)

Access to cardiovascular medicines in low- and middle-income countries: a mini review
por: Harrison, Mark Amankwa, et al.
Publicado: (2023)

The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review
por: Stolbrink, Marie, et al.
Publicado: (2022)

Cancer Prevention in Low- and Middle-Income Countries
por: Dey, Subhojit, et al.
Publicado: (2017)

Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries
por: Leopold, Christine, et al.
Publicado: (2014)

Adverse Events to SARS-CoV-2 (COVID-19) Vaccines and Policy Considerations that Inform the Funding of Safety Surveillance in Low- and Middle-Income Countries: A Mixed Methods Study
por: Ogar, Comfort K., et al.
Publicado: (2023)

The Availability, Pricing, and Affordability of Essential Diabetes Medicines in 17 Low-, Middle-, and High-Income Countries
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2019)

Medicine shortages: impact behind numbers
por: Postma, Doerine J., et al.
Publicado: (2023)

National medicines policies – a review of the evolution and development processes
por: Hoebert, Joëlle M, et al.
Publicado: (2013)

Preventing COVID-19 in low- and middle-income countries
por: Khadka, Sitaram, et al.
Publicado: (2020)

Impact of medicine shortages on patients - a framework and application in the Netherlands
por: Postma, Doerine J., et al.
Publicado: (2022)

Impact of regulatory requirements on medicine registration in African countries – perceptions and experiences of pharmaceutical companies in South Africa
por: Narsai, Kirti, et al.
Publicado: (2012)

Strategies for Genomic Medicine Education in Low- and Middle-Income Countries
por: Sirisena, Nirmala D., et al.
Publicado: (2019)

Essential Medicines in a High Income Country: Essential to Whom?
por: Duong, Mai, et al.
Publicado: (2015)

Newborn weight nomograms in selected low and middle-income countries
por: Ginsburg, Amy Sarah, et al.
Publicado: (2023)

Prevention, management, and rehabilitation of stroke in low- and middle-income countries
por: Yan, Lijing L., et al.
Publicado: (2016)

Virtual Infection Prevention and Control in Low- and Middle-Income Countries
por: Jones, Tristan, et al.
Publicado: (2022)

Use of Non-Steroidal Anti-Inflammatory Drugs That Elevate Cardiovascular Risk: An Examination of Sales and Essential Medicines Lists in Low-, Middle-, and High-Income Countries
por: McGettigan, Patricia, et al.
Publicado: (2013)

Interventions for the prevention of cardiovascular diseases: a protocol for a systematic review of economic evaluations in low-income and middle-income countries
por: Aminde, Leopold Ndemnge, et al.
Publicado: (2016)

Primary and secondary prevention interventions for cardiovascular disease in low-income and middle-income countries: a systematic review of economic evaluations
por: Aminde, Leopold Ndemnge, et al.
Publicado: (2018)

Quality assurance of medicines supplied to low-income and middle-income countries: poor products in shiny boxes?
por: Nebot Giralt, A, et al.
Publicado: (2017)

Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries: a systematic review
por: Shroufi, Amir, et al.
Publicado: (2013)

Community-Based Interventions for Cardiovascular Disease Prevention in Low-and Middle-Income Countries: A Systematic Review
por: Ndejjo, Rawlance, et al.
Publicado: (2021)

Early life opportunities for prevention of diabetes in low and middle income countries
por: Hanson, Mark A, et al.
Publicado: (2012)

Editorial: Pharmacometrics—tools to assure optimal medicine use in low- and middle-income countries
por: Abulfathi, Ahmed A., et al.
Publicado: (2022)

Access to medicines through health systems in low- and middle-income countries
por: Ozawa, Sachiko, et al.
Publicado: (2019)

Variability in market uptake of psychotropic medications in Europe reflects cultural diversity
por: Hoebert, J. M., et al.
Publicado: (2017)

Emergency Medicine Training Programs in Low- and Middle-Income Countries: A Systematic Review
por: Rybarczyk, Megan M., et al.
Publicado: (2020)

Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries
por: Stolbrink, M., et al.
Publicado: (2022)

Availability of cytotoxic medicines in the WHO essential medicine list used in treating childhood malignancies in low-income and lower-middle-income countries: a systematic review protocol
por: Seneviwickrama, Maheeka, et al.
Publicado: (2023)

Rotavirus vaccine protection in low-income and middle-income countries
por: Ramakrishnan, Girija, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ki4fue91etlo0p1kd7h044pf79